Cargando…
Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy
BACKGROUND: The aim of this study was to evaluate the prognostic potential of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) tumor tissue levels and examine the association between these biomarkers and classical prognostic factors in early node-negative...
Autores principales: | Jevrić, Marko, Matić, Ivana Z., Krivokuća, Ana, Đorđić Crnogorac, Marija, Besu, Irina, Damjanović, Ana, Branković-Magić, Mirjana, Milovanović, Zorka, Gavrilović, Dušica, Susnjar, Snezana, Kisić Tepavčević, Darija, Stanojković, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332605/ https://www.ncbi.nlm.nih.gov/pubmed/30646864 http://dx.doi.org/10.1186/s12885-018-5255-z |
Ejemplares similares
-
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994) -
Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014) -
Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer
por: Märkl, Bruno, et al.
Publicado: (2019) -
Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study
por: Märkl, Bruno, et al.
Publicado: (2017) -
uPA‐PAI‐1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophils
por: Uhl, Bernd, et al.
Publicado: (2021)